Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2014
Pharmacy Choice - News - U.S. Pharmaceutical Industry - September 22, 2014

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/22/14 - "Compositions and Methods for Reducing a Fatty Acid Desaturation Index in a Subject in Need Thereof" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Cardiovascular Week A patent application by the inventors Braeckman, Rene; Stirtan, William; Soni, Paresh, filed on February 28, 2014, was made available online on September 11, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned
9/22/14 - "Method for Producing Pressure-Sensitive Adhesive Tape Package" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Miyachika, Takafumi; Takada, Kiyotaka, filed on October 23, 2012, was made available online on September 11, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Hisami
9/22/14 - "Methods for Improving Brain Development and Cognitive Function Using Beta-Hydroxy-Beta Methylbutyrate" in Patent Application Approval Process
By a News Reporter-Staff News Editor at Mental Health Weekly Digest A patent application by the inventors Pedrosa, Jose Maria Lopez; Martin, Manuel Manzano; Perez, Alejandro Barranco; Gonzalez, Maria Ramirez; Cabrera, Ricardo Rueda, filed on February 13, 2012, was made available online on September 11, 2014, according to news reporting originatin
9/22/14 - Abbott Laboratories' Trademark Application for "ACCELERATOR AUTOMATED PROCESSING SYSTEMS" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ACCELERATOR AUTOMATED PROCESSING SYSTEMS" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Mic
9/22/14 - Acadia Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Sept. 4, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on September 4, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial state
9/22/14 - Acceleron Pharma Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Sept. 4, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on September 4, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement s
9/22/14 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Sept. 10, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on September 10, 2014. The SEC file number is 0001193125-14-337609.. A U.S. Securities and Exchange Commission
9/22/14 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Sept. 5, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on September 5, 2014. The SEC file number is 0001193125-14-333436.. A U.S. Securities and Exchange Commission f
9/22/14 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Sept. 9, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on September 9, 2014. The SEC file number is 0001193125-14-336206.. A U.S. Securities and Exchange Commission f
9/22/14 - Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
By a News Reporter-Staff News Editor at Pharma Business Week Afferent Pharmaceuticals, a leader in the development of small molecule compounds targeting P2X3 for respiratory, urologic and pain disorders, announced that Kathleen Sereda Glaub has been named Chief Executive Officer. Ms. Glaub had been serving as an independent member of Afferent's B
9/22/14 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Exceptions or Alternatives to Labeling...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled "Exceptions Or Alternatives to Labeling...
9/22/14 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the...
All comments should be identified with the OMB control number 0910-0697. Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. By qualitative feedback, FDA
9/22/14 - Alexion Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Sept. 4, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on September 4, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial stat
9/22/14 - Allergan's Trademark Application for "GLAUPREXA" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "GLAUPREXA" by Susan J. Hinchey, representing Allergan. The owner/registrar information for this application is: Susan J. Hinchey, Allergan, 2525 Dupont Dr, Ir
9/22/14 - Allergan's Trademark Application for "XBRIA" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "XBRIA" by Susan J. Hinchey, representing Allergan. The owner/registrar information for this application is: Susan J. Hinchey, Allergan, 2525 Dupont Dr, Irvine
9/22/14 - Amag Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Sept. 8, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on September 8, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial stateme
9/22/14 - Amag Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Sept. 8, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on September 8, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial stateme
9/22/14 - Amag Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Sept. 8, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amag Pharmaceuticals Inc. was posted on September 8, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial stateme
9/22/14 - An Application for the Trademark "ABBOTT MOBILE HEALTH" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ABBOTT MOBILE HEALTH" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Abbo
9/22/14 - An Application for the Trademark "AKAZEP" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "AKAZEP" by Marilyn F. Kelly, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Marilyn F. Kelly, Bristol-Myers Squib
9/22/14 - An Application for the Trademark "AZIVIO" Has Been Filed by Teva Pharmaceuticals
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "AZIVIO" by Herschel Perel, representing Teva Pharmaceuticals. The owner/registrar information for this application is: Herschel Perel, Teva Pharmaceuticals, 4
9/22/14 - An Application for the Trademark "CCISEV" Has Been Filed by Gilead Sciences
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "CCISEV" by Gretchen R. Stroud, representing Gilead Sciences. The owner/registrar information for this application is: Gretchen R. Stroud, Gilead Sciences, 333
9/22/14 - An Application for the Trademark "CORGLUTAN" Has Been Filed by Eli Lilly
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "CORGLUTAN" by Robert E. Lee, Jr., representing Eli Lilly. The owner/registrar information for this application is: Robert E. Lee, Jr., Eli Lilly, Lilly Corpor
9/22/14 - An Application for the Trademark "DASCERN" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Clinical Trials Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "DASCERN" by Marilyn F. Kelly, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Marilyn F. Kelly, Bristol-Myers Squi
9/22/14 - An Application for the Trademark "EPAREM" Has Been Filed by Eli Lilly
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "EPAREM" by Robert E. Lee, Jr., representing Eli Lilly. The owner/registrar information for this application is: Robert E. Lee, Jr., Eli Lilly, Lilly Corporate
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415